PUBLISHER: The Business Research Company | PRODUCT CODE: 1947060
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947060
A remote blood draw dried spot device is a medical tool used to collect small blood samples from patients remotely, often in home settings, by applying the blood onto specialized filter paper or absorbent material. The collected dried blood spots can then be safely transported to a laboratory for testing, allowing convenient monitoring of health parameters without the need for traditional venous blood draws.
The main product types of remote blood draw dried spot devices include filter paper devices, microfluidic devices, and others. Filter paper devices are designed to collect and preserve small blood samples on treated paper, providing a convenient, stable, and easily transportable method for dried blood spot testing. The supported sample types include whole blood, plasma, serum, and others, and these products are distributed through direct sales, online retail, pharmacies, and other channels. They are used in various applications such as disease diagnosis, therapeutic drug monitoring, newborn screening, forensic testing, and others, and serve end users including hospitals and clinics, diagnostic laboratories, research institutes, home care settings, and others.
Tariffs have increased costs of microfluidic components, filter papers, and plastic consumables used in dried-spot blood collection devices, particularly affecting manufacturers in Asia-Pacific supplying global markets. While tariffs have raised operational costs, they are also accelerating regional production, eco-friendly materials, and innovation in compact diagnostic sampling solutions.
The remote blood-draw dried-spot device market research report is one of a series of new reports from The Business Research Company that provides remote blood-draw dried-spot device market statistics, including remote blood-draw dried-spot device industry global market size, regional shares, competitors with a remote blood-draw dried-spot device market share, detailed remote blood-draw dried-spot device market segments, market trends and opportunities, and any further data you may need to thrive in the remote blood-draw dried-spot device industry. This remote blood-draw dried-spot device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The remote blood-draw dried-spot device market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.05 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to growth in remote diagnostics, need for patient convenience, expansion of lab testing services, newborn screening programs, telemedicine growth.
The remote blood-draw dried-spot device market size is expected to see rapid growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to home healthcare expansion, chronic disease monitoring, digital pathology growth, logistics optimization, population health management. Major trends in the forecast period include at-home blood sample collection, mail-in diagnostic testing, minimal invasive sampling devices, microfluidic blood collection, decentralized diagnostic testing.
The growing emphasis on personalized medicine is expected to drive the growth of the remote blood-draw dried-spot device market in the coming years. Personalized medicine involves tailoring medical treatments and preventive strategies based on an individual's unique genetic, molecular, and clinical characteristics to achieve better health outcomes. The adoption of personalized medicine is increasing as advances in genomics make it possible to identify genetic variations that influence disease susceptibility and treatment response, enabling more targeted and effective therapies. Remote blood-draw dried-spot devices support this approach by allowing convenient, at-home collection of small blood samples, facilitating frequent monitoring of biomarkers and genetic information to guide individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer therapies and three for other conditions. Therefore, the rising focus on personalized medicine is driving the growth of the remote blood-draw dried-spot device market.
Major companies in the remote blood-draw dried-spot device market are developing advanced decentralized sampling solutions to enable at-home blood collection, enhance patient convenience, and improve clinical trial efficiency. Decentralized sampling involves collecting biological samples outside traditional clinical settings, such as at home or in local facilities, allowing broader participation, faster sample turnaround, and improved data accessibility. For example, in March 2025, Tasso Inc., a US-based healthcare technology company, introduced next-generation dried blood spot (DBS) sampling technology designed for clinical trials and sports anti-doping testing. This innovation provides a virtually painless, accurate, and user-friendly method for blood collection, enabling precise volumetric sampling and high-quality data generation. By simplifying the sampling process and reducing participation barriers, the technology enhances compliance, accelerates drug development, and supports decentralized healthcare and research models.
In April 2025, Boston, a US-based biotechnology company, partnered with Nanowear Inc. to develop advanced wearable biosensors for continuous health monitoring. The collaboration aims to transform home-based healthcare by integrating AI-powered nanotechnology diagnostics with blood-based sampling and drug delivery patches. This combined digital health platform enables precise, continuous, and patient-friendly diagnostics and therapeutics, promoting the shift from clinic-centered to decentralized personalized care. Nanowear Inc., a US-based technology company, offers remote blood-draw dried-spot devices that complement these innovations in wearable biosensing and digital health monitoring.
Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)
North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote blood-draw dried-spot device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the remote blood-draw dried-spot device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The remote blood-draw dried-spot device market consists of sales of capillary blood collection kits, prepaid sample mailers, and integrated smart collection devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Remote Blood-Draw Dried-Spot Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses remote blood-draw dried-spot device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for remote blood-draw dried-spot device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remote blood-draw dried-spot device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.